InnoScience (Suzhou) Technology Holding Co., Ltd. has released the agenda for its Annual General Meeting (AGM) scheduled for 22 May 2026, outlining key operational, capital-management and governance resolutions.
Financial Highlights • 2025 performance remained loss-making; as a result, the Board recommends no profit distribution for the year. • Full 2025 financial statements and ESG disclosures have been published on HKEX and the company’s website for shareholder review.
Capital & Liquidity Measures • Subsidiary Guarantees: The company seeks shareholder approval to provide guarantees of up to RMB1.01 billion to support subsidiary production, operations and expansion. The aggregate limit can be used on a revolving basis through the conclusion of the 2026 AGM. • Issue Mandate: Directors request authority to issue up to 183.02 million new shares—equivalent to 20% of the existing issued share capital (excluding any treasury shares). • Repurchase Mandate: The Board also seeks capacity to buy back up to 52.55 million H shares, representing 10% of the current H-share float.
Audit & Fees • KPMG is nominated for re-appointment as external auditor for 2026. The audit fee is capped at RMB3.50 million, subject to final work scope.
Director Compensation • 2025 Actual Payments (selected executives): – Chairperson Dr. Weiwei Luo: RMB3.99 million (total) – CEO Dr. Wu Jingang: RMB5.46 million – CFO Mr. Zhong Shan: RMB2.39 million • 2026 Proposed Packages: – Dr. Luo: RMB4.61 million (salary + bonus) – Dr. Wu: RMB7.00 million – Mr. Zhong: RMB2.43 million – Non-executive directors will receive no base remuneration; independent non-executive directors to receive a monthly allowance of RMB40,000 before tax.
Shareholder Logistics • H-share register closes 19–22 May 2026; shareholders must lodge transfers by 18 May 2026 to vote. • Proxy forms must be submitted to Tricor Investor Services by 4:00 p.m. on 21 May 2026.
If approved, the mandates will grant the Board flexibility to raise capital, manage liquidity and support subsidiary growth while maintaining prudent oversight of audit and remuneration frameworks.